• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
  • New
Advances in Systemic Therapy for Lung Cancer, An Issue of Thoracic Surgery Clinics

Advances in Systemic Therapy for Lung Cancer, An Issue of Thoracic Surgery Clinics

9780443415135
604.75 zł
514.04 zł Save 90.71 zł Tax included
Lowest price within 30 days before promotion: 514.04 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Thoracic Surgery Clinics, guest editors Drs. Brendon M. Stiles and Tamar B. Nobel bring their considerable expertise to the topic of Advances in Systemic Therapy for Lung Cancer. Recent advances in systemic therapies, marked by ongoing clinical trials and new drug approvals, have revolutionized the treatment landscape, offering new hope for patients with lung cancer. This issue features articles by top experts who explore various topics including novel neoadjuvant and adjuvant clinical trials that could redefine standard care protocols.
Product Details
Elsevier
104217
9780443415135
9780443415135

Data sheet

Publication date
2025
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
178 x 254
Weight (g)
450
  • Neoadjuvant Immunotherapy
    Neoadjuvant Chemoimmunotherapy
    Neoadjuvant Tyrosine Kinase Inhibitors
    Surgical Challenges After Neoadjuvant Therapy
    Adjuvant Immunotherapy in Lung Cancer: Foundational Successes and Future Directions
    The Evolving Role of Adjuvant TKI in Lung Cancer: From Historical Trials to Future Strategies National Cancer Center Hospital East, Japan
    Neoadjuvant, Adjuvant, or Both? Optimizing Perioperative Systemic Therapy in Lung Cancer
    Adding Immunotherapy and Targeted Therapy to Chemoradiotherapy for Non-small Cell Lung Cancer
    Update on Neoadjuvant and Adjuvant Trials
    Advances in Systemic Therapy for Lung Cancer: Update on Biomarkers and Novel Drugs for Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC)
    Role of Surgery for Patients with Metastatic Non-small Cell Lung Cancer
Comments (0)